BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7813331)

  • 21. Constitutive endocytosis and degradation of CD22 by human B cells.
    Shan D; Press OW
    J Immunol; 1995 May; 154(9):4466-75. PubMed ID: 7722303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A; Babusíková O
    Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
    Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
    J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
    Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
    Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
    Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
    Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stages of B-lymphocyte differentiation in acute lymphoblastic leukemia].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Guzikowska E; Janik-Moszant A; Wieczorek M; Hołowiecki J
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):879-81, 884. PubMed ID: 2487942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular CD22 rapidly moves to the cell surface in a tyrosine kinase-dependent manner following antigen receptor stimulation.
    Sherbina NV; Linsley PS; Myrdal S; Grosmaire LS; Ledbetter JA; Schieven GL
    J Immunol; 1996 Nov; 157(10):4390-8. PubMed ID: 8906814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines.
    Koníková E; Babusíková O; Kusenda J; Glasová M
    Neoplasma; 1992; 39(6):337-42. PubMed ID: 1491722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation.
    Pizzolo G; Vincenzi C; Nadali G; Veneri D; Vinante F; Chilosi M; Basso G; Connelly MC; Janossy G
    Leukemia; 1994 Apr; 8(4):672-6. PubMed ID: 8152264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
    Echeverri C; Fisher S; King D; Craig FE
    Am J Clin Pathol; 2002 Apr; 117(4):615-20. PubMed ID: 11939737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
    Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
    Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
    Viemann D; Schlenke P; Hammers HJ; Kirchner H; Kruse A
    Eur J Immunol; 2000 Feb; 30(2):550-9. PubMed ID: 10671211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia.
    Donnard M; Guglielmi L; Turlure P; Piguet C; Couraud MJ; Bordessoule D; Denizot Y
    Stem Cells; 2002; 20(5):394-401. PubMed ID: 12351810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
    Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
    BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
    Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
    Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
    Wan S; Gong W; Sun X; Xu J; Tian D
    Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular antigen determination by flow cytometry in leukaemic cells.
    Chin SF; Cheong SK
    Malays J Pathol; 1994 Jun; 16(1):69-73. PubMed ID: 16329579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.